Skip to content
Screener

AngioDynamics ANGO Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

ICU Medical logo
ICU MedicalICUI
$49.85M-20.4%
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
$1.31M-9.2%
IAR
Integra LifeSciencesIART
$176.58M+1.8%
PDE
Pro-Dex, Inc.PDEX
$1.68M+28.9%
Microbot Medical logo
Microbot MedicalMBOT
$876K—

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M—
CapEx$413.0K-46.8%
Free cash flow$17.0M—

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S2×+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%—

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiability.

The source filing: AngioDynamics’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 3:42 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-048138
(in thousands)Balance Sheet LocationMay 31, 2026May 31, 2025
Assets
Operating lease ROU assetsOther assets$5,053$3,850
Liabilities
Current operating lease liabilitiesOther current liabilities1,2961,840
Non-current operating lease liabilitiesOther long-term liabilities3,8602,106
Total lease liabilities$5,156$3,946

Item 15. Exhibits, Financial Statement Schedules.

FAQ

What is AngioDynamics's operating lease liabilities (total)?
AngioDynamics (ANGO) reported operating lease liabilities (total) of $5.16M in Q1 2026.
How has AngioDynamics's operating lease liabilities (total) changed year-over-year?
AngioDynamics's operating lease liabilities (total) increased by 30.7% year-over-year, from $3.95M to $5.16M.
What is the long-term trend for AngioDynamics's operating lease liabilities (total)?
Over 5 years (2021 to 2026), AngioDynamics's operating lease liabilities (total) has grown at a -11.9% compound annual growth rate (CAGR), from $9.73M to $5.16M.
What does operating lease liabilities (total) mean?
This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.

Ask your AI about AngioDynamics's operating lease liabilities (total).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude